Security key
10778Y112
BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW)
CUSIP: 10778Y112
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / *W EXP 02/26/202
- Total 13F shares
- 495,142
- Total 13F value
- $1,217,751
- Share change
- -133,650
- SEC-reported price per share
- $2.47
- Number of holders
- 4
- Value change
- -$330,261
- Number of buys
- 1
- Number of sells
- 2
Report period
Q3 2023
Institutions
4
Top holders
4
BCTXW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BriaCell Therapeutics Corp. SEC filings
BriaCell Therapeutics Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10778Y112
Recent filing periods:
Ownership snapshot
Top reported holders of BCTXW - BriaCell Therapeutics Corp. - *W EXP 02/26/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynwood Capital Managemen...
Disclosed value leader
Lynwood Capital Managemen...
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F
3/4/5
Highest disclosed value: $10,168,497
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Lynwood Capital Management Inc. has the largest disclosed position value at $10.17M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynwood Capital Management Inc.'s linked filing trail.
Disclosed position value
Top 5
Lynwood Capital Management Inc.
$10.17M
WASATCH ADVISORS LP
$3.93M
Redmond Asset Management, LLC
$1.07M
ARMISTICE CAPITAL, LLC
$937.5K
Jamieson Bondarenko
$777.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. |
13F
Company
|
—
denominator unverified
|
$10,168,497
1,583,878 shares
|
— | 30 Jun 2023 |
| WASATCH ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$3,929,605
612,088 shares
|
— | 30 Jun 2023 |
| Redmond Asset Management, LLC |
13F
Company
|
—
mixed-class rows
|
$1,071,463
212,689 shares
mixed-class rows
|
— | 30 Jun 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$937,500
375,000 shares
|
— | 30 Jun 2023 |
| Jamieson Bondarenko |
3/4/5
Chairman, Director
|
—
denominator unverified
|
$777,940
169,856 shares
|
— | 28 Dec 2022 |
| NATIXIS |
13F
Company
|
—
denominator unverified
|
$579,405
90,250 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
495,142
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q4 2025 Across Filers
Q4 2025 holders
6
Q3 2023 holders
4
Holder diff
-2
| Investor | Q4 2025 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend